• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项旨在根据精神分裂症和重度抑郁症治疗指南改善精神科医生临床行为的传播与教育计划:精神科治疗传播与教育指南的有效性(EGUIDE)项目。

A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders: the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project.

作者信息

Yamada Hisashi, Motoyama Mikuni, Hasegawa Naomi, Miura Kenichiro, Matsumoto Junya, Ohi Kazutaka, Yasui-Furukori Norio, Numata Shusuke, Takeshima Masahiro, Sugiyama Nobuhiro, Nagasawa Tatsuya, Kubota Chika, Atake Kiyokazu, Tsuboi Takashi, Ichihashi Kayo, Hashimoto Naoki, Inagaki Takahiko, Takaesu Yoshikazu, Iga Jun-Ichi, Hori Hikaru, Onitsuka Toshiaki, Komatsu Hiroshi, Hishimoto Akitoyo, Fukumoto Kentaro, Fujimoto Michiko, Nakamura Toshinori, Nemoto Kiyotaka, Furihata Ryuji, Yamamura Satoshi, Yamagata Hirotaka, Ogasawara Kazuyoshi, Katsumoto Eiichi, Murata Atsunobu, Iida Hitoshi, Ochi Shinichiro, Makinodan Manabu, Kido Mikio, Kishimoto Taishiro, Yasuda Yuka, Usami Masahide, Suwa Taro, Inada Ken, Watanabe Koichiro, Hashimoto Ryota

机构信息

Department of Neuropsychiatry, Hyogo College of Medicine, Japan; and Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Japan.

Department of Neuropsychiatry, Hyogo College of Medicine, Japan.

出版信息

BJPsych Open. 2022 Apr 21;8(3):e83. doi: 10.1192/bjo.2022.44.

DOI:10.1192/bjo.2022.44
PMID:35446248
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9059732/
Abstract

BACKGROUND

Clinical practice guidelines for schizophrenia and major depressive disorder have been published. However, these have not had sufficient penetration in clinical settings. We developed the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project as a dissemination and education programme for psychiatrists.

AIMS

The aim of this study is to assess the effectiveness of the EGUIDE project on the subjective clinical behaviour of psychiatrists in accordance with clinical practice guidelines before and 1 and 2 years after participation in the programmes.

METHOD

A total of 607 psychiatrists participated in this study during October 2016 and March 2019. They attended both 1-day educational programmes based on the clinical practice guidelines for schizophrenia and major depressive disorder, and answered web questionnaires about their clinical behaviours before and 1 and 2 years after attending the programmes. We evaluated the changes in clinical behaviours in accordance with the clinical practice guidelines between before and 2 years after the programme.

RESULTS

All of the scores for clinical behaviours in accordance with clinical practice guidelines were significantly improved after 1 and 2 years compared with before attending the programmes. There were no significant changes in any of the scores between 1 and 2 years after attending.

CONCLUSIONS

All clinical behaviours in accordance with clinical practice guidelines improved after attending the EGUIDE programme, and were maintained for at least 2 years. The EGUIDE project could contribute to improved guideline-based clinical behaviour among psychiatrists.

摘要

背景

精神分裂症和重度抑郁症的临床实践指南已经发布。然而,这些指南在临床环境中的渗透还不够充分。我们开展了精神科治疗指南传播与教育有效性(EGUIDE)项目,作为针对精神科医生的传播与教育计划。

目的

本研究旨在评估EGUIDE项目对精神科医生在参与项目前以及参与项目1年和2年后依据临床实践指南的主观临床行为的有效性。

方法

2016年10月至2019年3月期间,共有607名精神科医生参与了本研究。他们参加了基于精神分裂症和重度抑郁症临床实践指南的为期1天的教育项目,并在参加项目前以及参加项目1年和2年后回答了关于其临床行为的网络问卷。我们评估了项目前与项目后2年之间依据临床实践指南的临床行为变化。

结果

与参加项目前相比,在参加项目1年和2年后,所有依据临床实践指南的临床行为得分均有显著提高。参加项目1年和2年后的任何得分之间均无显著变化。

结论

参加EGUIDE项目后,所有依据临床实践指南的临床行为均得到改善,并至少维持了2年。EGUIDE项目有助于提高精神科医生基于指南的临床行为。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06e8/9059732/b7064061c461/S2056472422000448_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06e8/9059732/b7064061c461/S2056472422000448_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/06e8/9059732/b7064061c461/S2056472422000448_fig1.jpg

相似文献

1
A dissemination and education programme to improve the clinical behaviours of psychiatrists in accordance with treatment guidelines for schizophrenia and major depressive disorders: the Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE) project.一项旨在根据精神分裂症和重度抑郁症治疗指南改善精神科医生临床行为的传播与教育计划:精神科治疗传播与教育指南的有效性(EGUIDE)项目。
BJPsych Open. 2022 Apr 21;8(3):e83. doi: 10.1192/bjo.2022.44.
2
Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.使用“精神科治疗指南传播与教育有效性(EGUIDE)”项目提高精神科医生对精神分裂症和重度抑郁症治疗指南的临床知识:一项全国范围的传播、教育和评估研究。
Psychiatry Clin Neurosci. 2019 Oct;73(10):642-648. doi: 10.1111/pcn.12911. Epub 2019 Aug 22.
3
The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study.教育对精神分裂症和重度抑郁症治疗指南的影响以及对精神科医生催眠药物处方行为的影响:一项多中心研究。
BMC Psychiatry. 2024 May 29;24(1):399. doi: 10.1186/s12888-024-05816-x.
4
Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study.精神分裂症和抑郁症治疗指南相关教育对精神科医生治疗行为的影响:一项多中心研究。
Psychiatry Clin Neurosci. 2023 Oct;77(10):559-568. doi: 10.1111/pcn.13578. Epub 2023 Sep 8.
5
Satisfaction with web-based courses on clinical practice guidelines for psychiatrists: Findings from the "Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)" project.基于网络的精神科临床实践指南课程的满意度:“精神科治疗指南传播与教育效果(EGUIDE)”项目的研究结果。
Neuropsychopharmacol Rep. 2023 Mar;43(1):23-32. doi: 10.1002/npr2.12300. Epub 2022 Nov 28.
6
Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study.在一项全国范围内的传播和实施研究中,对精神分裂症和重度抑郁症治疗指南的理解程度有所提高。
Neuropsychopharmacol Rep. 2021 Jun;41(2):199-206. doi: 10.1002/npr2.12173. Epub 2021 Mar 11.
7
Prescription patterns in patients with schizophrenia in Japan: First-quality indicator data from the survey of "Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)" project.日本精神分裂症患者的处方模式:来自“精神科治疗指南传播与教育有效性调查(EGUIDE)”项目的第一质量指标数据。
Neuropsychopharmacol Rep. 2020 Sep;40(3):281-286. doi: 10.1002/npr2.12122. Epub 2020 Jun 30.
8
Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment project.精神分裂症或重度抑郁症患者出院处方的特点:来自推广和教育指南(EGUIDE)精神科治疗项目的真实世界证据。
Asian J Psychiatr. 2021 Sep;63:102744. doi: 10.1016/j.ajp.2021.102744. Epub 2021 Jul 15.
9
The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the "Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)" project.来自“精神治疗中指南传播与教育的有效性(EGUIDE)”项目调查的、针对精神分裂症和重度抑郁症患者按需使用精神药物的出院处方特征。
Ann Gen Psychiatry. 2022 Dec 26;21(1):52. doi: 10.1186/s12991-022-00429-8.
10
The characteristics of patients receiving psychotropic pro re nata medication at discharge for the treatment of schizophrenia and major depressive disorder: A nationwide survey from the EGUIDE project.接受精神科按需药物治疗出院的精神分裂症和重度抑郁症患者的特征:来自 EGUIDE 项目的全国性调查。
Asian J Psychiatr. 2022 Mar;69:103007. doi: 10.1016/j.ajp.2022.103007. Epub 2022 Jan 13.

引用本文的文献

1
Association between pharmacological guideline adherence and actigraphy-measured sleep variables in long-term hospitalized patients with schizophrenia.长期住院的精神分裂症患者中,药物治疗指南依从性与通过活动记录仪测量的睡眠变量之间的关联。
PCN Rep. 2025 Jul 10;4(3):e70154. doi: 10.1002/pcn5.70154. eCollection 2025 Sep.
2
Associations between clozapine availability, the diagnosis of treatment-resistant schizophrenia subgroups, antipsychotic monotherapy, and concomitant psychotropics among patients with schizophrenia: a real-world nationwide study.氯氮平可及性、难治性精神分裂症亚组诊断、抗精神病药物单药治疗与精神分裂症患者联用精神药物之间的关联:一项全国性真实世界研究
Int J Neuropsychopharmacol. 2025 Apr 11;28(4). doi: 10.1093/ijnp/pyaf011.
3

本文引用的文献

1
Japanese Society of Neuropsychopharmacology: "Guideline for Pharmacological Therapy of Schizophrenia".日本神经精神药理学学会:《精神分裂症药物治疗指南》
Neuropsychopharmacol Rep. 2021 Sep;41(3):266-324. doi: 10.1002/npr2.12193. Epub 2021 Aug 12.
2
Characteristics of discharge prescriptions for patients with schizophrenia or major depressive disorder: Real-world evidence from the Effectiveness of Guidelines for Dissemination and Education (EGUIDE) psychiatric treatment project.精神分裂症或重度抑郁症患者出院处方的特点:来自推广和教育指南(EGUIDE)精神科治疗项目的真实世界证据。
Asian J Psychiatr. 2021 Sep;63:102744. doi: 10.1016/j.ajp.2021.102744. Epub 2021 Jul 15.
3
The effect of education regarding treatment guidelines for schizophrenia and major depressive disorders on psychiatrists' hypnotic medication prescribing behavior: a multicenter study.教育对精神分裂症和重度抑郁症治疗指南的影响以及对精神科医生催眠药物处方行为的影响:一项多中心研究。
BMC Psychiatry. 2024 May 29;24(1):399. doi: 10.1186/s12888-024-05816-x.
4
Better adherence to guidelines among psychiatrists providing pharmacological therapy is associated with longer work hours in patients with schizophrenia.在为精神分裂症患者提供药物治疗的精神科医生中,更好地遵循指南与患者更长的工作时间相关。
Schizophrenia (Heidelb). 2023 Nov 7;9(1):78. doi: 10.1038/s41537-023-00407-3.
5
Factors associated with the initiation of laxative use in the same patients with schizophrenia over a 20-year period: Retrospective cohort study.20年间同一组精神分裂症患者开始使用泻药的相关因素:回顾性队列研究。
Neuropsychopharmacol Rep. 2024 Mar;44(1):60-66. doi: 10.1002/npr2.12378. Epub 2023 Sep 12.
6
Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study.精神分裂症和抑郁症治疗指南相关教育对精神科医生治疗行为的影响:一项多中心研究。
Psychiatry Clin Neurosci. 2023 Oct;77(10):559-568. doi: 10.1111/pcn.13578. Epub 2023 Sep 8.
7
Change of prescription for patients with schizophrenia or major depressive disorder during admission: real-world prescribing surveys from the effectiveness of guidelines for dissemination and education psychiatric treatment project.精神分裂症或重度抑郁症患者住院期间的处方变更:从指南传播和教育精神科治疗项目的效果看真实世界的处方调查。
BMC Psychiatry. 2023 Jun 28;23(1):473. doi: 10.1186/s12888-023-04908-4.
8
The characteristics of discharge prescriptions including pro re nata psychotropic medications for patients with schizophrenia and major depressive disorder from the survey of the "Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)" project.来自“精神治疗中指南传播与教育的有效性(EGUIDE)”项目调查的、针对精神分裂症和重度抑郁症患者按需使用精神药物的出院处方特征。
Ann Gen Psychiatry. 2022 Dec 26;21(1):52. doi: 10.1186/s12991-022-00429-8.
9
Development of an individual fitness score (IFS) based on the depression treatment guidelines of in the Japanese Society of Mood Disorders.基于日本心境障碍学会的抑郁治疗指南制定个体健康评分(IFS)。
Neuropsychopharmacol Rep. 2023 Mar;43(1):33-39. doi: 10.1002/npr2.12301. Epub 2022 Nov 16.
10
Development of individual fitness score for conformity of prescriptions to the "Guidelines For Pharmacological Therapy of Schizophrenia".制定个体适应性评分以规范处方与《精神分裂症药物治疗指南》的一致性。
Neuropsychopharmacol Rep. 2022 Dec;42(4):502-509. doi: 10.1002/npr2.12293. Epub 2022 Oct 18.
Improvements in the degree of understanding the treatment guidelines for schizophrenia and major depressive disorder in a nationwide dissemination and implementation study.
在一项全国范围内的传播和实施研究中,对精神分裂症和重度抑郁症治疗指南的理解程度有所提高。
Neuropsychopharmacol Rep. 2021 Jun;41(2):199-206. doi: 10.1002/npr2.12173. Epub 2021 Mar 11.
4
Unmet needs of patients with major depressive disorder - Findings from the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.重度抑郁症患者未满足的需求——“精神科治疗指南传播与教育的有效性(EGUIDE)”项目的研究结果:一项全国性的传播、教育与评估研究。
Psychiatry Clin Neurosci. 2020 Dec;74(12):667-669. doi: 10.1111/pcn.13143. Epub 2020 Oct 9.
5
Nudge strategies to improve healthcare providers' implementation of evidence-based guidelines, policies and practices: a systematic review of trials included within Cochrane systematic reviews.推动策略以改善医疗保健提供者实施基于证据的指南、政策和实践:Cochrane 系统评价中包含的试验的系统评价。
Implement Sci. 2020 Jul 1;15(1):50. doi: 10.1186/s13012-020-01011-0.
6
Prescription patterns in patients with schizophrenia in Japan: First-quality indicator data from the survey of "Effectiveness of Guidelines for Dissemination and Education in psychiatric treatment (EGUIDE)" project.日本精神分裂症患者的处方模式:来自“精神科治疗指南传播与教育有效性调查(EGUIDE)”项目的第一质量指标数据。
Neuropsychopharmacol Rep. 2020 Sep;40(3):281-286. doi: 10.1002/npr2.12122. Epub 2020 Jun 30.
7
Network analysis of the depressive symptom profiles in Asian patients with depressive disorders: Findings from the Research on Asian Psychotropic Prescription Patterns for Antidepressants (REAP-AD).抑郁障碍亚洲患者抑郁症状谱的网络分析:来自亚洲抗抑郁药精神处方模式研究(REAP-AD)的结果。
Psychiatry Clin Neurosci. 2020 Jun;74(6):344-353. doi: 10.1111/pcn.12989. Epub 2020 Mar 5.
8
Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.使用“精神科治疗指南传播与教育有效性(EGUIDE)”项目提高精神科医生对精神分裂症和重度抑郁症治疗指南的临床知识:一项全国范围的传播、教育和评估研究。
Psychiatry Clin Neurosci. 2019 Oct;73(10):642-648. doi: 10.1111/pcn.12911. Epub 2019 Aug 22.
9
Trends of Polypharmacy and Prescription Patterns of Antidepressants in Asia.亚洲多重用药趋势及抗抑郁药处方模式
J Clin Psychopharmacol. 2018 Dec;38(6):598-603. doi: 10.1097/JCP.0000000000000954.
10
Polypharmacy and psychotropic drug loading in patients with schizophrenia in Asian countries: Fourth survey of Research on Asian Prescription Patterns on antipsychotics.亚洲国家精神分裂症患者的药物滥用和精神药物负荷:亚洲抗精神病药物处方模式研究第四次调查。
Psychiatry Clin Neurosci. 2018 Aug;72(8):572-579. doi: 10.1111/pcn.12676. Epub 2018 Jun 19.